Daily vs Weekly Testosterone Injections: What Really Changes, and Which Fits You
Compare daily, twice-weekly, and weekly testosterone injections on steadiness, evidence, FDA labeling, monitoring, cost, fertility, and practical fit.
Published 2026-09-20 · Last updated 2026-09-20
Last verified: September 2026
Editorial research, not clinically reviewed. Sources checked September 20, 2026.
Educational information, not medical advice. Testosterone is a Schedule III controlled substance in the United States and requires a valid prescription. Chest pain, trouble breathing, or a swollen, painful leg can be signs of a blood clot. Get urgent or emergency care now.
Daily vs weekly testosterone injections comes down to steadiness versus simplicity. More frequent injections should reduce peak-to-trough variation when the same total weekly amount is divided into smaller doses, but we found no study showing daily injections work better or are safer than weekly injections in men with testosterone deficiency. Weekly is 52 shots a year instead of 365. Our simple half-life model estimates a much smaller theoretical swing with daily dosing, but it is not a prediction of your personal blood levels.
What changes the answer: whether low testosterone has been properly confirmed, whether you're trying to have kids, your hematocrit, whether you need an FDA-approved medicine or insurance, and how you honestly feel about needles.
And here's the part the daily-injection ads leave out. The only study we found that compared twice-weekly shots with weekly ones found more blood-thickening problems in the twice-weekly group, not fewer. It has real limits, and we'll walk through them. But it's a good reason to slow down before you pay for a schedule.
- 52 vs 365 — shots a year, weekly vs daily
- ~61% vs ~9% — the theoretical peak-to-trough swing in our simplified exponential-decay model using the label's roughly eight-day IM half-life; this is not a measured daily-vs-weekly clinical result
- 0 — head-to-head studies of daily vs weekly injections in men with low testosterone that we could find
| This page is for you if… | Start somewhere else if… |
|---|---|
| You're on weekly shots and feel flat a day or two before the next one | Low testosterone hasn't been confirmed with repeat early-morning blood tests |
| You're starting TRT and every clinic seems to push a different schedule | You're trying to conceive now or soon |
| You saw "daily microdosing" in an ad and want the straight story | Your hematocrit has already been flagged as high |
TRT Provider Guide is the independent decision resource for testosterone replacement therapy — helping U.S. adults understand how low testosterone is evaluated, compare online and local care models and providers, and choose the next step that fits their health needs, fertility plans, budget, state, and care preferences, with every material claim verified and dated.
Jump to what sounds like you:
- "I'm not on TRT yet." → Which schedule fits your situation?
- "I'm on weekly and I crash before my next shot." → Is it better to inject testosterone daily or weekly?
- "I'm on daily and it's wearing on me." → Is twice weekly the best middle ground?
Daily vs weekly testosterone injections: how do they compare?
Both schedules can use the same testosterone and the same total amount each week if a prescriber chooses to divide the weekly amount that way. What changes is how many shots you take and the expected size of the peak-to-trough swing. Weekly uses one injection; daily uses seven. Daily programs commonly use under-the-skin injections, but route and frequency are separate decisions.
Here's the whole comparison on one screen. The "How sure are we?" column is the part most pages skip.
| Decision point | Weekly | Twice weekly | Daily | How sure are we? |
|---|---|---|---|---|
| Shots per year | 52 | 104 | 365 | Arithmetic |
| Swing around your average level* | ~61% | ~30% | ~9% | Simple math from the label's half-life. Real curves vary by person and injection method |
| Shown to feel better or be safer than the others? | Not shown | Not shown | Not shown | No head-to-head study found |
| Matches the FDA label for testosterone cypionate? | No. The label says every 2 to 4 weeks | No | No | FDA label, read September 20, 2026 |
| FDA-approved product labeled for this schedule | Xyosted, an under-the-skin autoinjector | None | None. Xyosted's instructions say not to use it daily | FDA label |
| If you miss one shot | Do not assume a catch-up plan; ask your prescriber | Same | Same | Missed-dose instructions are product- and prescription-specific |
| When blood is usually drawn | Midway between shots, or right before the next one, depending on the product | Ask | Timing matters less. Still ask | Endocrine Society guideline; Xyosted label |
| Easiest for | Busy schedules, travel, insurance, FDA-approved products | Most of the smoothing, far fewer needles | People who want the flattest line and like a daily routine | Our judgment |
| Watch-outs | A late-week dip for some men | Still two shots a week | 365 needles a year; mostly cash-pay compounded programs | Verified provider pages |
| Example program, year one at published prices | Taurus Meds ≈ $1,837 in advertised parts | Hone Health (physician sets the schedule) ≈ $2,001–$2,261 | Male Excel ≈ $2,727 + shipping | Provider pages, September 20, 2026 |
*Swing = how far your level moves above and below its average over the time between shots, assuming the same weekly amount on every schedule. It's based on the FDA label's roughly eight-day half-life for testosterone cypionate. It is not your personal lab result. See how we calculated it.
The right TRT provider is not the same for every person — it depends on whether low testosterone has been properly evaluated, your symptoms and health history, your fertility plans, your state, your insurance or cash-pay preference, your treatment-format preference, your budget, and whether online or in-person care is the better starting point. Some situations belong with primary care, urology, endocrinology, reproductive urology, or urgent or emergency care when the symptoms warrant it. Because a general answer cannot resolve those for you, use TRT Provider Guide's Find My TRT Path tool to map your situation to the right care route and the questions to ask before you pay.
What stays the same no matter which schedule you pick: testosterone remains a Schedule III prescription drug, fertility still matters, and monitoring still matters. The total weekly amount may stay the same when frequency changes, but only if the prescriber keeps it the same. A schedule is the timing of treatment; it is not proof that one plan is stronger, safer, or better.
Commercial relationship disclosure: TRT Provider Guide has disclosed commercial relationships with Male Excel and Taurus Meds on current site pages. Hone Health is included without an affiliate relationship. Links on this page are informational unless a qualifying relationship is clearly disclosed next to the link. Read our affiliate disclosure.
Which schedule fits your situation?
Settle two bigger questions first: has low testosterone been confirmed, and are you trying to have kids soon? After that, the choice mostly comes down to how you feel late in your injection week, how you feel about needles, and whether you need an FDA-approved medicine or insurance. Find yourself below.
Not on TRT yet? The schedule is your second decision, not your first. The American Urological Association (AUA) says low testosterone should be diagnosed only after two early-morning blood tests on separate days, together with symptoms or signs. Get that right first. Then pick a schedule you'll actually keep.
On weekly, and you feel a dip before your next shot? Tell your prescriber when the symptoms happen and when your labs were drawn. A frequency change — including twice-weekly dosing in some practices — is one option a clinician may consider, but symptoms alone do not prove that the trough is the cause or that more frequent injections are the right fix.
On weekly, feeling good, labs look fine? Nothing says you have to change. The AUA's own goal is the least treatment needed to reach the target range. More needles aren't automatically better.
Hematocrit flagged? Hematocrit is the share of your blood made of red blood cells. When it runs high, blood gets thicker. Don't change anything on your own. Schedule is one thing your clinician can adjust, along with dose, your target level, and checking for sleep apnea.
Hate needles? Daily programs often use small subcutaneous needles, but they still mean seven injection events a week. Weekly subcutaneous treatment and the Xyosted autoinjector are different options to discuss with a prescriber. Or skip needles entirely — our injections vs gel guide covers that choice.
Need an FDA-approved medicine or insurance? Ask your own doctor, urologist, or another prescribing clinician about FDA-approved testosterone products and what your plan covers. The online programs compared later in this page advertise cash-pay compounded testosterone options; confirm the exact product and pharmacy before paying.
Trying to conceive? Neither schedule. Testosterone therapy can lower sperm production no matter how often you inject. See a reproductive urologist first — our fertility guide explains why.
Still sorting out where you fit? That's normal, and it's exactly what our tool is for. Map your care route with Find My TRT Path → It's free and educational. It won't diagnose you or promise a prescription, but it will hand you a care route and the questions to ask before you pay.
Is it better to inject testosterone daily or weekly?
Daily is not proven stronger or better. With the same weekly amount, our simplified exponential-decay model estimates a theoretical swing of about 61% for weekly dosing and about 9% for daily dosing. That model uses the label's roughly eight-day intramuscular half-life for testosterone cypionate; it does not model depot absorption or predict an individual's serum curve. No head-to-head study we found shows that the flatter theoretical line produces better clinical outcomes.
Why weekly shots rise and fall
Testosterone cypionate is testosterone with an oily "tail" attached so it releases slowly. The FDA label puts its half-life — the time it takes for half of it to clear — at about eight days when it's injected into muscle.
One shot a week means a rise after the shot and a slow fall before the next one. That low point is called the trough. The trough is the low point before the next dose. Some patients describe late-interval symptoms as a "crash," but symptoms alone do not prove that the trough is the cause. A review of injected cypionate studies describes levels climbing above the normal range within two to three days of a shot, then falling toward low by the end of the dosing interval. The longer the gap, the more room there is to fall.
How much steadier is daily? The swing table
We ran the numbers ourselves. Same weekly amount on every schedule. No doses needed.
| Schedule | Shots per year | Peak ÷ trough | Theoretical swing around average | Smoothing bought per extra shot |
|---|---|---|---|---|
| Every 2 weeks | 26 | 3.4× | ~121% | — |
| Weekly | 52 | 1.8× | ~61% | Baseline |
| Twice weekly | 104 | 1.35× | ~30% | ~0.58 points per extra shot |
| Every other day | ~183 | 1.2× | ~17% | — |
| Daily | 365 | 1.09× | ~9% | ~0.08 points per extra shot (twice weekly → daily) |
How we calculated it: We used the label's approximately eight-day intramuscular half-life in a simplified one-compartment, first-order elimination model at steady state. Swing = 0.693 × days between injections ÷ 8. Peak ÷ trough = 2 raised to the power of (days between injections ÷ 8). This is an illustration of frequency alone, not a validated pharmacokinetic model for depot testosterone cypionate, subcutaneous dosing, or any individual patient. We calculated it on September 20, 2026.
What the table tells you:
- Twice weekly delivers about 58% of all the smoothing daily offers.
- The last 42% costs 261 more shots a year.
- Each extra shot buys a lot of steadiness at first, then very little. That's the part nobody puts in the ad.
Reality check: real bodies aren't spreadsheets
The table is arithmetic about frequency alone. Real levels also depend on where the shot goes and how your body absorbs it. Two real-world measurements are worth knowing:
- Xyosted, the FDA-approved weekly subcutaneous testosterone enanthate autoinjector, had a mean week-12 Cmax of 790 ng/dL and Cmin of 436 ng/dL — a ratio of about 1.8. That similar number does not validate our cypionate model because Xyosted uses a different ester, route, formulation, and delivery system.
- In a small study of 11 transgender men on weekly under-the-skin cypionate, average testosterone was about the same six hours after the shot as it was five days later. Individual results varied a lot, and it was a different population than men with low testosterone. Still, it shows weekly doesn't have to mean a crash for everyone.
So yes: more frequent shots flatten the curve. How much that matters for you depends on your route, your body and your dose.
Flatter isn't automatically better
Your body's own testosterone isn't a flat line either; it's typically higher in the morning. A flatter curve is a feature of the drug, not a health result. Whether it makes you feel better, or lowers side effects, is a separate question. That's the next section.
We'll say this plainly: one of our commercial partners sells daily injections. We still can't tell you daily is better, because the evidence isn't there. What we can do is show you exactly what is and isn't known.
What does the research actually show?
Less than the marketing on either side suggests. We couldn't find a published study comparing daily and weekly injections head-to-head in men with low testosterone. The few studies that compare schedules are small, look back at old charts, and point in different directions.
We pulled the most relevant published studies and abstracts we could verify that bear on injection schedule or route. Here's what each found — and what it can't tell you.
| Study | What it compared | What it found | What it can't tell you |
|---|---|---|---|
| Ohlander et al., 2016 (AUA meeting abstract, 55 men) | Once weekly vs twice weekly injections | Hematocrit above 52%: 11% on weekly vs 29% on twice weekly | Men were switched to twice weekly because symptoms came back early, and weekly totals weren't matched. Small and retrospective |
| El-Khatib et al., 2022 (International Journal of Impotence Research, 263 men) | Weekly vs every two weeks, into muscle | Hematocrit above 54%: 1% weekly vs 8% every two weeks. No significant differences in estradiol or PSA | Doesn't test daily. The authors tied the risk to higher average testosterone |
| Choi et al., 2022 (Journal of Urology, 234 men) | Weekly shot into muscle vs weekly under-the-skin autoinjector | The under-the-skin group had lower estradiol and hematocrit | Both groups were weekly. Different route, different form, different device — not frequency |
| McFarland et al., 2017 (Journal of the Endocrine Society, 11 people) | Weekly under-the-skin cypionate, measured 8 times across the week | Average levels stayed steady between shots | Weekly only; transgender men, not men with low testosterone |
| SubQ cypionate, 2022 (Journal of Sexual Medicine, 94 men) | Under-the-skin cypionate, weekly or "biweekly" | 32% developed new erythrocytosis | Shows under-the-skin shots don't make hematocrit issues disappear |
| Xyosted pharmacokinetics (Andrology, 2022) | Weekly under-the-skin autoinjector | Peak about 1.8× the low point | Weekly only |
| AlphaMD (a clinic that prescribes every schedule) | Its patients' results | About 90% do best on twice weekly; says it doesn't have enough data to compare schedules at the same weekly dose | A clinic's own report, not a study |
| Daily vs weekly in men with low testosterone | — | We found no published study | — |
The study that points the other way
The 2016 Baylor abstract is the only study we found that tested going beyond weekly. It found the opposite of what the ads promise: more men crossed the high-hematocrit line on twice-weekly shots. (At the other end, weekly beat every-two-week shots in the 2022 study. Frequency clearly matters somewhere — just not in the simple "more is always better" way.)
Before anyone waves it around, two big caveats. The twice-weekly men were moved there because their symptoms returned before the next shot, so they weren't the same kind of patient. And their weekly totals weren't the same as the weekly group's. That's why this is a warning sign, not a verdict.
It does settle one thing: nobody can honestly say "more frequent shots lower hematocrit" as a proven fact.
What it would take to prove daily is better
A real answer would need the same kind of men, the same testosterone product, the same route, and the same weekly amount — randomly assigned to daily or weekly. Blood drawn at the right times. Then symptoms, hematocrit, estradiol and blood pressure tracked for months. That study hasn't been published. Until it is, "daily is proven better" is marketing.
Why we don't publish doses
You'll find pages that list daily milligram amounts and dose calculators. We don't. Your dose depends on the diagnosis, exact product, laboratory results, response, adverse effects, and clinician judgment. A number copied from a website cannot safely determine an individual prescription. Bring questions, not numbers.
Do daily injections lower estrogen or hematocrit?
Maybe, but it isn't proven. Lower peaks are often proposed as a reason more frequent dosing might change estradiol or red-blood-cell effects, but direct daily-vs-weekly evidence is thin and mixed. When researchers compared weekly with every-two-week shots, they tied the extra high-hematocrit cases to higher average testosterone — so your target level matters at least as much as how often you inject.
Estradiol is the main form of estrogen. Some testosterone naturally converts into it. Erythrocytosis means too many red blood cells, which pushes hematocrit up.
Claim reality check
| What you'll hear | Our verdict | Why |
|---|---|---|
| "Daily gives you flatter levels." | True on paper | Smaller, more frequent shots shrink the swing. The size depends on route and person |
| "Weekly always causes a crash." | False as a blanket claim | Weekly under-the-skin shots stayed steady in a small study; Xyosted's swing was modest |
| "Daily is proven to feel better." | Not established | No head-to-head study found |
| "More frequent shots lower hematocrit." | Unproven — one study found the opposite | Twice weekly had more erythrocytosis in the Baylor abstract. Weekly beat every two weeks in another study. Neither tested daily |
| "Daily lets you drop your estrogen blocker." | Not established | No trial. That's a decision for your clinician, not a schedule change |
| "Studies show SubQ lowers hematocrit." | Overstated | The best-known study compared two weekly products that differed in route, form and device |
| "If I dip before my shot, I should inject more often." | Not a safe conclusion on your own | Lab timing, dose, target level and the original diagnosis all matter |
Target first, schedule second
This is the part almost nobody talks about. Before you compare schedules, compare the target level your clinician is aiming for.
| Who | Target testosterone level on treatment |
|---|---|
| AUA guideline | 450–600 ng/dL, using the minimum dose necessary to reach that therapeutic range |
| Endocrine Society | Mid-normal range |
| Male Excel (its own daily-vs-weekly page) | 800–1,100 ng/dL |
A daily plan aiming high is a different plan from a weekly plan aiming for the middle — whatever the calendar says. In the weekly vs every-two-weeks study, the researchers linked erythrocytosis to higher average testosterone. So ask your clinician what target they're using for you, and why.
Why doctors watch hematocrit so closely
The AUA says a hematocrit of 54% or higher on testosterone warrants action, such as lowering the dose or pausing treatment. The Endocrine Society also flags hematocrit above 54% and says to look for low oxygen and sleep apnea. It also says the exact hematocrit level at which clot or heart risk rises isn't known. That's why the answer to a high number is a clinician's plan, not a schedule you pick yourself.
Are daily or weekly testosterone injections FDA-approved?
Neither daily nor once-weekly use matches the labeled interval for the Depo-Testosterone and Azmiro testosterone cypionate products checked for this page, which specify intramuscular use every two to four weeks. Xyosted is FDA-approved for once-weekly subcutaneous testosterone enanthate. Clinicians may prescribe an approved drug off label when medically appropriate, but off-label use is not the same as FDA-approved dosing.
We read the labels. Here's what they actually say.
| Product | FDA-approved? | How the label says to give it | How often |
|---|---|---|---|
| Depo-Testosterone (testosterone cypionate, Pfizer) and FDA-approved generics | Yes | Into muscle only, deep in the buttock | Every 2 to 4 weeks |
| Azmiro (testosterone cypionate, single-dose vial or prefilled syringe) | Yes | Deep into the buttock muscle only; the prefilled syringe is given by a healthcare professional | Every 2 to 4 weeks |
| Xyosted (testosterone enanthate autoinjector) | Yes | Under the skin of the belly | Once a week — "Do not use XYOSTED every day." |
| Compounded testosterone cypionate | No | Not FDA-approved as a compounded preparation; administration depends on the prescription and pharmacy directions | Depends on the prescription and pharmacy directions |
What this means:
- Weekly cypionate is off-label too. Some pages imply weekly is the "FDA-approved" schedule. The cypionate label says every two to four weeks.
- Daily is off-label, and so is under-the-skin cypionate. None of the labels we checked calls for daily injections.
- Off-label isn't illegal. Clinicians can prescribe an approved drug on a schedule outside its label when they judge it right for you. But it isn't the same as FDA-approved dosing — on either side.
FDA-approved, off-label, and compounded are three different things
| Term | What it means |
|---|---|
| FDA-approved, used as labeled | An approved product given the way its label says |
| FDA-approved, used off-label | An approved product given a different way or on a different schedule |
| Compounded | A preparation mixed by a pharmacy. It is not FDA-approved, and approval can't be borrowed from the products above |
"Bioidentical" is a marketing word, not an FDA category. If a program uses it, ask one question: Is my vial an FDA-approved product or a compounded preparation?
Are the labels changing?
Yes, but not about schedules. On June 18, 2026, HHS announced that FDA is requesting updates to testosterone labels about age-related low testosterone, prostate cancer, and enlarged prostate. None of those requested changes is about how often to inject. Testosterone remains a Schedule III controlled substance that needs a valid prescription.
Need FDA-approved medicine or insurance coverage? That points you to a different care route than the online programs below. Find My TRT Path can help you map it.
Is SubQ vs IM the same question as daily vs weekly?
No. Route (where the needle goes) and frequency (how often) are separate. A daily program like Male Excel's switches both at once — from a shot into muscle to a shot under the skin — so any difference a man notices can't be credited to frequency alone.
- Intramuscular (IM) means into muscle, usually the buttock or thigh, with a longer needle.
- Subcutaneous (SubQ) means into the fat just under the skin, usually the belly or thigh, with a short, thin needle.
Here's why this matters. The most-quoted "SubQ lowers hematocrit" study compared two weekly products. The small study showing steady levels also used weekly under-the-skin shots. So if what bothers you is the needle or the late-week dip, "weekly under the skin" is a real option to ask about — not just "daily."
Evidence that under-the-skin shots work is not evidence that daily under-the-skin shots are better. Keep those two ideas apart and most of the marketing gets easier to read.
What is it like to inject daily vs weekly?
Daily programs commonly use a small subcutaneous injection every day — about 365 injection events a year. Weekly means 52 injection events a year and can be intramuscular or subcutaneous depending on the exact product and prescription. Missed-dose instructions are prescription-specific, so neither schedule should be treated as automatically "forgiving."
| Practical point | Weekly into muscle | Weekly under the skin | Twice weekly under the skin | Daily under the skin |
|---|---|---|---|---|
| Shots a year | 52 | 52 | 104 | 365 |
| Needle, as providers describe it | 1 to 1.5 inches into thigh or glute (Male Excel's description of IM shots) | Short needle, or the Xyosted autoinjector | 27-gauge, ½-inch (Hone's under-the-skin guide) | 31-gauge insulin needle (Male Excel) |
| Sharps to throw away | Least | Low | Medium | Most — about 7× weekly |
| Miss one shot | Ask your prescriber for a product-specific plan | Ask your prescriber | Ask your prescriber | Ask your prescriber |
| Travel | Plan around one shot | Same | Plan two | Supplies every day |
The habit test
The Endocrine Society lists treatment burden — how hard a treatment is to live with — as one factor in choosing a testosterone regimen, alongside your preference, how the drug behaves in the body, and cost. So be honest with yourself.
Do you take a daily pill without thinking about it? Daily might feel the same. Do you forget vitamins by Wednesday? Weekly is kinder. A schedule you actually follow beats a flatter one you skip.
If you miss a shot
A missed dose changes the intended schedule, but the effect depends on the product, route, prescription, and timing. Don't work out a catch-up on your own. Ask your prescriber what to do before you start, and get the instruction in writing.
Under-the-skin shots have quirks too
Small lumps, redness or itching at the injection spot can happen. Rotate sites the way your prescriber or pharmacist shows you. If a spot gets hot, swollen or painful, call them.
Does a daily program still sound like the care model you want to compare?
If you've read this far and still want to compare a program built around daily subcutaneous injections, Male Excel is one current example. Choosing that care model should follow a clinical evaluation, not the theoretical swing table.
Male Excel does not offer a weekly injection schedule. Daily under-the-skin shots are its only injection option, and at published prices it's the priciest of our three partners — about $2,727 for year one plus shipping ($99 consultation + $99/month required membership + $120/month medication, billed every other month). If one shot a week is your priority, Hone Health (whose physicians set the schedule) or your own doctor is the better fit. If price comes first, check the cost table below.
Because Male Excel publishes a daily-only injection model, its injection program is built around that schedule. Each 60-day supply comes with 60 insulin-type syringes. Its page describes a 31-gauge needle under the skin, not a deep shot into muscle. Its $99 membership includes unlimited messaging with its support team, unlimited online visits with your provider, and a symptom check every two months — useful when you're doing something 365 times a year.
Before you click, know these five things. We'd want to know them too:
- Its target is higher than the AUA's. Its own page says it aims for 800–1,100 ng/dL; the AUA's range is 450–600. Ask what target your provider will use for you, and why.
- Thyroid comes bundled. The injection plan includes daily thyroid tablets. Ask whether you need them and what the plan costs without them.
- Medication status. Male Excel calls its cypionate "bioidentical." When we checked on September 8, 2026, it described its testosterone as compounded, which means not FDA-approved. Confirm for your prescription.
- Follow-up labs. Male Excel's current main TRT page says its $99 monthly membership includes comprehensive blood testing every 6 months, while an older daily-vs-weekly page still says yearly testing. Ask which schedule applies to the program you would actually enroll in. The Endocrine Society recommends checking hematocrit at baseline, 3 to 6 months after starting treatment, and then annually.
- Where it works. Its FAQ lists 11 states it doesn't serve (Alabama, Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Minnesota, Mississippi, New Hampshire and Rhode Island). It's cash pay, and its site says an in-person exam may be required under DEA and state law.
See Male Excel's published daily injection plan and current pricing → Public provider link. Starts with a $99 consultation/testing offer on the page checked. A clinician decides whether treatment is appropriate; a prescription is not guaranteed.
Want to compare every clinic that offers daily shots? Our TRT providers with daily injections guide lays out Male Excel's fine print, AlphaMD and a local Michigan program side by side.
Is twice weekly the best middle ground?
Twice-weekly dosing is one frequency some clinicians use, and it sits between weekly and daily in injection burden. In our simplified model it cuts the theoretical weekly swing roughly in half with 104 injections a year instead of 365. It is not proven better than daily or weekly, and the model cannot identify a medically "best" frequency.
The numbers, side by side
- Weekly → twice weekly: swing drops from ~61% to ~30%, for 52 more shots a year.
- Twice weekly → daily: swing drops from ~30% to ~9%, for 261 more shots a year.
What a clinic that offers every schedule reports
AlphaMD prescribes weekly, twice weekly, every other day, three times weekly and daily. Its published answer says about 90% of men get their best results on twice weekly. In the same set of answers, it says it doesn't have enough data to compare schedules at the same weekly dose. That's a clinic's own report, not a study. But it's an honest look at what real-world clinicians land on when every option is on the table.
What about every other day?
About 183 injection events a year and roughly a 17% theoretical swing in our simplified model. The injection day shifts through the week, which can make the schedule harder to track.
Want a physician to pick the schedule with you?
If you'd rather not pre-commit to daily or weekly, choose a program where the physician sets the schedule after reviewing your labs — and can change it.
Hone Health doesn't publish one standard schedule on the pages we checked. Its help center has both an under-the-skin guide and an into-muscle guide, and its own cost article says injections are usually given one to three times a week. A few things we like for this decision:
- Confirmation testing. Hone's help center says men moving toward testosterone therapy need a confirmatory lab test. That lines up with guideline advice to confirm low testosterone with repeat testing.
- Live physician visits. It describes a private one-on-one video consultation with board-certified physicians.
- It says the quiet part out loud. Its testosterone page states the product is compounded and not FDA-approved.
What it costs: Hone's help center lists a Plus plan built for men's TRT at $135/month (from $180 to start, including the first test and first month). Its main TRT page lists Basic ($25/month) and Premium ($155/month). Testosterone is from $28/month on top. Year one at the starting medication price runs about $2,001 on Plus or $2,261 on Premium, before any confirmatory test fee or dose change. Ask which plan your prescription needs, because Hone's own pages list different options.
Review Hone's lab-first TRT process and membership prices → Public provider link. Hone is included without an affiliate relationship. A clinician reviews the clinical information before any prescription; a prescription is not guaranteed.
How much do daily vs weekly testosterone injections cost?
The schedule itself does not determine the total bill. If the same product and total weekly amount are simply divided differently, medication use may be similar; in real care, the prescription, supplies, membership, labs, shipping, pharmacy, and dose can all change the cost. What changes the bill most in the programs below is the program structure. At published prices, year one runs about $2,727 plus shipping at Male Excel (daily), about $2,001–$2,261 at Hone Health (physician-set), and $1,837 in advertised parts at Taurus Meds (weekly).
We added up each program's published price parts. These are our calculations, not quotes.
| Care route | Schedule | Start-up | Ongoing | Year one at published prices | What's not included |
|---|---|---|---|---|---|
| Male Excel | Daily, under the skin | $99 consultation + at-home test | $99/month required membership + medication "starting at $120/month," billed every other month | $2,727 | Shipping; any dose change changes the price |
| Hone Health — Plus | Physician-set | $45 test (listed as part of a $180 start) | $135/month + testosterone from $28/month | ~$2,001 | Confirmatory test fee if required; dose changes |
| Hone Health — Premium | Physician-set | $65 biomarker test | $155/month + testosterone from $28/month | ~$2,261 | Same |
| Taurus Meds | Weekly wording on its page | $49 blood test + consultation | $149/month, "all inclusive," per its page | $1,837 in advertised parts | Its Terms list a $17.99 membership fee per billing period "unless otherwise stated" at purchase — ask. At $17.99 a month, that would add $215.88 |
| AlphaMD (not a partner) | Mostly twice weekly; any schedule possible | Confirm | $98–$129/month plan fees, depending on commitment | $1,176–$1,548 in plan fees (checked September 8, 2026) | Initial and lab charges — confirm |
| Your own doctor + insurance | Whatever your prescriber agrees to | Visit + lab copays | Generic cypionate copay | Depends on your plan | Syringes if you switch to under-the-skin |
Two things that change the math:
- Syringes. Daily uses about 365 a year, twice weekly 104, weekly 52. Male Excel includes 60 per 60-day supply. Elsewhere, ask.
- Insurance. Coverage depends on the plan, diagnosis, product, pharmacy benefit, prior-authorization rules, and prescriber. Do not assume a schedule itself is covered or excluded. The online programs compared here advertise cash-pay care; if insurance matters, compare an in-network clinician and covered FDA-approved product before paying cash.
We earn nothing from AlphaMD or your own doctor. We list them because they may cost you less. Our TRT cost guide goes deeper on every line.
Which online TRT providers offer daily, weekly, or flexible schedules?
Among our partners, Male Excel prescribes daily under-the-skin injections as its standard plan, Hone Health lets the physician set the schedule, and Taurus Meds' page describes weekly injections into muscle. If you need an FDA-approved medicine billed to insurance, an in-network primary-care clinician, urologist, endocrinologist, or other appropriate prescriber may fit that goal better than a cash-pay compounded program.
| Route | Default schedule | Can you ask for another? | Medication status | Good fit for |
|---|---|---|---|---|
| Male Excel | Once daily, under the skin | No weekly injection option published | Its term: "bioidentical." Described as compounded when we checked September 8, 2026 | Men set on daily who want a program built around it |
| Hone Health | None published; physician-set | Yes | Compounded, not FDA-approved (its own page) | Men who want a physician to choose weekly, twice weekly or other |
| Taurus Meds | Weekly, into muscle (its product text) | Not published — ask | Its page says compounded in the U.S. | Price-focused weekly readers who'll confirm the details |
| AlphaMD (not a partner) | About 90% twice weekly | Yes — lists every schedule | Confirm | Flexibility and lower plan fees |
| Your own doctor or specialist | Individualized to product and clinical plan | Discuss with prescriber | May prescribe an FDA-approved brand/generic when appropriate | Insurance or FDA-approved-product path |
| Xyosted (any prescriber) | Weekly | No — labeled weekly only | FDA-approved | Men who want an approved weekly under-the-skin product |
A few Taurus Meds details worth knowing before you choose it:
- The line "Weekly intramuscular injections clinically proven to 5x testoerone levels" appears under its testosterone card — and is repeated word for word under its enclomiphene, gel and sermorelin cards. Confirm that weekly injections are actually your plan.
- Its page says its medications are compounded "specifically for The Excel Advantage HRT program." Male Excel uses "The Excel Advantage" for its own program. We couldn't confirm whether the companies are related. If you want two truly independent options, ask each in writing.
- Its Terms say sales on shipped medications are final and blood work isn't refundable. Its page advertises a 90-day guarantee "minus lab and pharmacy fees."
See our Male Excel vs Taurus Meds comparison for the full side-by-side, or see Taurus's current $49 starting offer (public provider link; confirm current terms before paying).
When should you get blood work on each schedule?
It depends on the product and schedule. For weekly or every-two-week cypionate, the Endocrine Society suggests checking testosterone midway between shots, while Xyosted's label uses the level right before the next weekly dose. On daily schedules, the theoretical peak-to-trough change is smaller, but there is no schedule-specific guideline saying timing does not matter. Follow the prescriber's lab-timing instructions and document when the last injection occurred.
| Schedule | When the guideline or label says to draw blood | Why | Ask this |
|---|---|---|---|
| Weekly or every 2 weeks, cypionate or enanthate | Midway between injections (Endocrine Society) | Your level on day 1 and day 6 can differ a lot | "Midway, or right before my next shot?" |
| Xyosted weekly | The low point, 7 days after a dose, first after 6 weeks of treatment (label) | That's the label's method | — |
| Twice weekly | No schedule-specific guideline found | The swing is smaller, but timing still shifts the number | "What day and time, relative to my shot?" |
| Daily | No schedule-specific guideline found | Use a consistent, clinician-specified timing | "Before or after that day's shot?" |
| Any schedule | Hematocrit at baseline, again at 3 to 6 months, then yearly (Endocrine Society) | It's the side effect that most often limits injections | "Will you check hematocrit a few months after I change schedules?" |
A schedule change can make your old labs misleading
Say your last test was drawn two days after a weekly shot, and your next one is drawn on a daily schedule. The numbers aren't measuring the same moment. One might look "better" or "worse" when nothing really changed. Write down when you injected and when you had blood drawn — every time — and give that to your clinician.
Give a new schedule time to settle
Xyosted's label waits six weeks after starting, or after any dose change, before checking levels. Other schedules may also require time before a new steady pattern can be assessed, but the interval depends on the product and clinical plan. Follow the prescriber's timing rather than copying Xyosted's six-week rule to another product. Our TRT blood test guide covers what should be checked and when.
Can you switch from weekly to daily injections?
Yes, a prescriber can change injection frequency when clinically appropriate. Do not assume the weekly total should stay the same or that a specific follow-up interval applies to every product; confirm the new prescription and lab timing with the treating clinician. If you like your current clinician, ask them first — you may not need a new provider at all.
Ask your current prescriber first
If you're happy with your care and just want to try a different schedule, this is a normal request. Bring a clear description of your week. Not "I feel bad." More like: "Great days one through three, flat by five, done by six." Then ask the questions below.
The schedule switch questions
Copy these into a message or print them for your visit:
- What testosterone level are you aiming for with me, and why?
- If we change how often I inject, will my weekly total stay the same?
- When exactly should my next blood test be — which day, and before or after that day's shot?
- Will that test include hematocrit, estradiol and PSA?
- Is my testosterone an FDA-approved product or compounded, and which pharmacy fills it?
- Is under-the-skin OK for my prescription, and which syringes will I get?
- Will a new schedule change my price — syringes, shipping, refills?
- What should I do if I miss a shot on the new schedule? Can you put that in writing?
The two that do most of the work: #2 and #3. They keep a schedule change from quietly turning into a dose change, and they keep your next lab result meaningful.
Bring this too: your exact product name from the label, the route on your prescription, the dates and times of your last few injections, and the date and time of your last blood draw.
If your prescriber says no
There are good reasons a clinician might: your hematocrit, your labs, how consistent you've been, or simply that the label and their experience favor your current schedule. Ask what would change their mind. You can also get a second opinion or choose a program built around the schedule you want. Don't stop your current prescription to qualify somewhere else; coordinate any change with your treating clinicians.
Online care, state rules and the December 31, 2026 date
- The federal rule. Testosterone is a Schedule III controlled substance. DEA and HHS have extended the COVID-era telemedicine flexibilities for prescribing controlled medications through December 31, 2026, when the federal requirements are met. The rules after that date can change, so ask any online program what requirements apply when you enroll rather than relying on a prediction about a future rule.
- Your state. Federal flexibility doesn't override state law. Some programs don't serve every state, and some may still require an in-person exam. Tell the provider where you'll physically be during visits.
Weighing online care against a local clinic? Our online vs local TRT guide covers that decision.
Who should talk to a specialist before choosing either schedule?
Schedule is a fine-tuning question. If low testosterone hasn't been confirmed, you're trying to conceive, your hematocrit is already high, or you have untreated severe sleep apnea, a recent heart attack or stroke, or a prostate or breast cancer history, start with primary care, urology or endocrinology instead.
Low testosterone isn't confirmed yet. The AUA calls for two early-morning tests on separate days plus symptoms or signs. The Endocrine Society's July 16, 2026 statement adds that tests should be accurate and standardized, and done on at least two early mornings while fasting. One finger-prick result or a symptom quiz is not a diagnosis.
You want children now or soon. The AUA says testosterone therapy should not be prescribed to men who are currently trying to conceive. Testosterone can reduce spermatogenesis — your body's production of sperm. No schedule, daily or otherwise, has been shown to protect fertility. Talk to a reproductive urologist before you pay any intake fee. Medicines like clomiphene work differently, aren't TRT, and aren't interchangeable with it — that's a separate conversation for that specialist.
Your hematocrit is already high, or you have untreated severe sleep apnea, a heart attack or stroke within the last six months, or a history of prostate or breast cancer. These need a clinician's evaluation, not a schedule choice from a comparison page.
You have headaches or vision changes along with very low testosterone. Ask about seeing an endocrinologist to check the pituitary gland.
Chest pain, trouble breathing, or a swollen, painful leg. Get urgent or emergency care now.
What did we actually verify?
We checked the sources on this page ourselves on September 20, 2026, except where we note an earlier date. Details from the Endocrine Society's 2018 guideline were read on September 8, 2026 and cross-checked today against its earlier edition and published summaries. This is a public-source comparison. We did not enroll with any provider, receive medication, or have a clinician review this page.
Sources checked at the source: FDA labels for Depo-Testosterone, Azmiro and Xyosted; the AUA testosterone deficiency guideline; the Endocrine Society guideline and its July 16, 2026 statement; the HHS June 18, 2026 labeling announcement; the Federal Register notice extending telemedicine flexibility through December 31, 2026; the published studies in our research table; Male Excel's pricing, injection, daily-vs-weekly and FAQ pages; Hone Health's TRT page, testosterone page and help-center membership and injection guides; Taurus Meds' $49 offer page and Terms of Service; and AlphaMD's published answers on injection frequency.
Verified facts: label routes and intervals, guideline standards and hematocrit thresholds, the federal telemedicine date, study findings, and each provider's published prices, schedules, state list and terms as they appeared on the dates shown.
Our own calculations: the swing table and every year-one total. Both show their math.
Provider-stated, not independently confirmed: schedules, what's included, needle sizes, targets, confirmation-testing policies, guarantee terms, and AlphaMD's "about 90% twice weekly" figure.
What we couldn't confirm: Male Excel's shipping charge; whether its injection plan can be bought without thyroid; whether Taurus's $17.99 membership fee applies to the $49 offer; whether Taurus Meds and Male Excel are related; which Hone plan a TRT prescription requires; and whether any head-to-head daily-vs-weekly study exists that we missed. AlphaMD's prices were last checked September 8, 2026.
Our full method is published at How We Review TRT Providers, along with our editorial standards. See something wrong or out of date? Tell us through our corrections page and we'll date the fix.
Frequently asked questions
Is it better to inject testosterone daily or weekly?
More frequent dosing should reduce peak-to-trough variation in a simplified model; weekly is simpler. We found no study showing daily leads to better results or fewer side effects in men with low testosterone. Twice weekly gets most of the smoothing with far fewer shots.
Can you inject testosterone every day?
Some prescribers use daily under-the-skin shots with small insulin-type syringes. That's outside the FDA label interval for testosterone cypionate, and Xyosted's instructions say not to use that product every day. Only change your schedule with your prescriber.
Is daily testosterone the same as "microdosing"?
Often, but the term is not standardized. Some clinics use "microdosing" to mean smaller, more frequent injections; do not assume it means the same weekly total or a specific schedule unless the prescriber defines it.
Do daily testosterone injections keep levels more stable?
Yes, on paper. In our half-life math, daily swings about 9% around your average versus about 61% on weekly. Real swings depend on your route and your body, and one small study found weekly under-the-skin shots already fairly steady.
Do daily injections lower estrogen?
It has not been proven head-to-head. Lower individual peaks are one proposed mechanism, but that is not enough to establish a clinical benefit. Decisions about estrogen blockers belong with your clinician, not with a schedule change.
Do daily injections lower hematocrit?
Not proven. One study found more high-hematocrit cases on twice-weekly shots than weekly, though it had important limits. Your dose and target level matter too.
Is twice weekly as good as daily?
It gets most of the way there: about a 30% swing versus 9% in our math, with 104 shots a year instead of 365. Neither has been proven to give better outcomes.
Do daily injections hurt less?
Daily subcutaneous programs often use small needles, but pain and tolerability vary. Daily dosing also means seven times as many injection events as weekly dosing.
Are weekly testosterone injections FDA-approved?
Weekly isn't the labeled schedule for testosterone cypionate, whose label says every two to four weeks. Xyosted is an FDA-approved product labeled for weekly under-the-skin use.
Do daily injections cost more?
If the exact product and total weekly amount stay the same, medication use may be similar, but supplies, dose, pharmacy pricing, shipping, labs, and program fees can change the total. See the cost table above.
When should I get blood work on daily injections?
There is no schedule-specific guideline we found for daily cypionate testing. Use a consistent timing set by your prescriber and record whether the sample was drawn before or after that day's injection.
Can I split my weekly dose into daily shots myself?
No. Changing frequency changes your prescription and how your labs should be read. Talk to your prescriber and plan a follow-up blood test.
Do daily injections protect fertility?
No. Any testosterone schedule can lower sperm production. If you're trying to conceive, see a reproductive urologist first.
What happens if I miss a daily shot?
Do not assume the effect of a missed daily injection from arithmetic alone. Ask your prescriber ahead of time what to do and get the instruction in writing.
Does insurance cover daily testosterone injections?
Insurance coverage depends on the plan, diagnosis, product, pharmacy benefit, prior authorization, and prescriber. Ask whether your plan covers the exact FDA-approved product and supplies prescribed for you; the online compounded programs compared here advertise cash-pay care.
Which online clinics offer daily injections?
Male Excel prescribes daily under-the-skin injections as its standard plan, and AlphaMD offers daily for some patients. See our TRT providers with daily injections guide for the full comparison.
Still not sure which TRT care route fits you? Use our free Find My TRT Path tool.
It's free and educational. It doesn't diagnose low testosterone, confirm eligibility, or guarantee a prescription. It helps you match your health, fertility plans, budget, insurance and state to a care route — plus the questions to ask before you pay.
TRT Provider Guide is the independent decision resource for testosterone replacement therapy care. We are not a clinic, pharmacy, laboratory, drug manufacturer, insurer, or medical practice. This page is educational information, not medical advice, and it cannot diagnose low testosterone or decide whether treatment is right for you. Only a licensed clinician can do that. Prices, policies and rules change; this page was last verified in September 2026.
Sources
All sources were checked September 20, 2026, unless another date is shown.
FDA labels and federal sources
- DailyMed: Depo-Testosterone (testosterone cypionate) prescribing information
- FDA: Azmiro (testosterone cypionate) label, 2025
- DailyMed: Xyosted (testosterone enanthate) prescribing information and instructions for use
- HHS: Requested updates to testosterone therapy product labels, June 18, 2026
- Federal Register: Fourth temporary extension of telemedicine flexibilities for controlled medications, through December 31, 2026
- Alliance for Connected Care: status of the DEA special registration rule
- Florida Blue medical coverage guideline 09-J1000-24 (generic cypionate and prior authorization)
Guidelines and statements
- American Urological Association: Testosterone Deficiency Guideline and guideline text, Journal of Urology
- Endocrine Society: Testosterone Therapy in Men With Hypogonadism, clinical practice guideline, 2018
- Endocrine Society: Statement on Testosterone Replacement Therapy, July 16, 2026
- Payer policy quoting the Endocrine Society's regimen factors (preference, pharmacokinetics, treatment burden, cost)
Studies
- Ohlander et al.: Twice per week dosing of intramuscular testosterone is associated with greater risk of erythrocytosis, Journal of Urology 2016 (AUA abstract MP76-05)
- El-Khatib et al.: Comparative assessment of two intramuscular testosterone regimens (weekly vs every other week), International Journal of Impotence Research 2022
- Choi et al.: IM testosterone cypionate vs SubQ testosterone enanthate autoinjector, Journal of Urology 2022
- McFarland et al.: Serum testosterone concentrations remain stable between injections in patients receiving subcutaneous testosterone, Journal of the Endocrine Society 2017
- Erythrocytosis in subcutaneous testosterone replacement therapy, Journal of Sexual Medicine 2022
- Pastuszak et al.: Pharmacokinetics of testosterone therapies, Andrology 2022
- Figueiredo et al.: Testosterone therapy with subcutaneous injections, Journal of Clinical Endocrinology & Metabolism 2022
- Short-Acting Testosterone: More Physiologic? (review of injectable pharmacokinetics)
Providers (first-party pages)
- Male Excel: Hormone treatment costs
- Male Excel: Testosterone cypionate injections
- Male Excel: Daily vs weekly testosterone injections
- Male Excel: TRT FAQs (state list)
- Hone Health: Online testosterone replacement therapy
- Hone Health: Testosterone cypionate injections (compounded disclosure)
- Hone Health help center: Membership overview — Basic, Plus and Premium
- Hone Health help center: Men's patient journey (confirmatory testing)
- Hone Health help center: Under-the-skin injection guide
- Hone Health: How much does testosterone cost? (November 2023)
- Taurus Meds: $49 testing offer and testosterone program
- Taurus Meds: Terms of Service (updated June 24, 2025)
- AlphaMD: Which injection frequency works best for most patients
- TRT Provider Guide: TRT Providers With Daily Injections (Male Excel compounded description and AlphaMD plan prices, checked September 8, 2026)
Ready to explore your options?
Our tool helps you narrow down the care route that fits your situation based on testing, budget, and fertility goals.
Find My TRT Path